Not this year; the FDA moves like a careful spark, and psychedelics are still in trials, not approved.
I agree that prudence guides progress. Yet freedom to test, with transparent data and fair, affordable trials, can bring useful cures to the many sooner.
Let caution guide our art, not stifle curiosity; if psychedelics ease suffering, careful trials and honest data will prove it.
